BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 30138157)

  • 1. The efficacy of fluorine-18-choline PET/CT in comparison with 99mTc-MIBI SPECT/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism.
    Araz M; Soydal Ç; Özkan E; Kir MK; İbiş E; Güllü S; Erdoğan MF; Emral R; Küçük ÖN
    Nucl Med Commun; 2018 Nov; 39(11):989-994. PubMed ID: 30138157
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
    Uslu-Beşli L; Sonmezoglu K; Teksoz S; Akgun E; Karayel E; Pehlivanoglu H; Khosroshahi BR; Ocak M; Kabasakal L; Sager S; Bukey Y
    Korean J Radiol; 2020 Feb; 21(2):236-247. PubMed ID: 31997599
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Mathey C; Keyzer C; Blocklet D; Van Simaeys G; Trotta N; Lacroix S; Corvilain B; Goldman S; Moreno-Reyes R
    J Nucl Med; 2022 May; 63(5):785-791. PubMed ID: 34413141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
    Thanseer N; Bhadada SK; Sood A; Mittal BR; Behera A; Gorla AKR; Kalathoorakathu RR; Singh P; Dahiya D; Saikia UN; Rao SD
    Clin Nucl Med; 2017 Dec; 42(12):e491-e497. PubMed ID: 28902729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
    Quak E; Blanchard D; Houdu B; Le Roux Y; Ciappuccini R; Lireux B; de Raucourt D; Grellard JM; Licaj I; Bardet S; Reznik Y; Clarisse B; Aide N
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):658-666. PubMed ID: 29270788
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Rep S; Hocevar M; Vaupotic J; Zdesar U; Zaletel K; Lezaic L
    J Radiol Prot; 2018 Mar; 38(1):343-356. PubMed ID: 29339573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Cervical Ultrasound,
    Boudousq V; Guignard N; Gilly O; Chambert B; Mamou A; Moranne O; Zemmour M; Sharara H; Lallemant B
    J Nucl Med; 2022 Jul; 63(7):1081-1086. PubMed ID: 34857659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.
    Morland D; Lalire P; Deguelte S; Zalzali M; Richard C; Dejust S; Boulagnon C; Ly S; Papathanassiou D; Delemer B
    Medicine (Baltimore); 2020 Jan; 99(2):e18681. PubMed ID: 31914064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between technetium-99m methoxyisobutylisonitrile scintigraphy and ultrasound in the diagnosis of parathyroid adenoma and parathyroid hyperplasia.
    Xue J; Liu Y; Ji T; Zhao A; Liang Y; Deng H; Wang Q; Zhang Y; Yang L; Yang A
    Nucl Med Commun; 2018 Dec; 39(12):1129-1137. PubMed ID: 30239472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
    Dudoignon D; Delbot T; Cottereau AS; Dechmi A; Bienvenu M; Koumakis E; Cormier C; Gaujoux S; Groussin L; Cochand-Priollet B; Clerc J; Wartski M
    Diagn Interv Imaging; 2022 May; 103(5):258-265. PubMed ID: 35039246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
    Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
    Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
    Michaud L; Balogova S; Burgess A; Ohnona J; Huchet V; Kerrou K; Lefèvre M; Tassart M; Montravers F; Périé S; Talbot JN
    Medicine (Baltimore); 2015 Oct; 94(41):e1701. PubMed ID: 26469908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L; Burgess A; Huchet V; Lefèvre M; Tassart M; Ohnona J; Kerrou K; Balogova S; Talbot JN; Périé S
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4531-6. PubMed ID: 25215560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PETC/CT with
    Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
    J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of
    Grimaldi S; Young J; Kamenicky P; Hartl D; Terroir M; Leboulleux S; Berdelou A; Hadoux J; Hescot S; Remy H; Baudin E; Schlumberger M; Deandreis D
    Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1772-1780. PubMed ID: 29680989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upfront F18-choline PET/CT versus Tc99m-sestaMIBI SPECT/CT guided surgery in primary hyperparathyroidism: the randomized phase III diagnostic trial APACH2.
    Quak E; Lasne Cardon A; Ciappuccini R; Lasnon C; Bastit V; Le Henaff V; Lireux B; Foucras G; Jaudet C; Berchi C; Grellard JM; Lequesne J; Clarisse B; Bardet S
    BMC Endocr Disord; 2021 Jan; 21(1):3. PubMed ID: 33413316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
    Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
    Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH; Chen HT; Lee MC; Liu SH; Wang LY; Lue KH; Chan SC
    Ann Nucl Med; 2020 Aug; 34(8):527-537. PubMed ID: 32436180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Kluijfhout WP; Vorselaars WM; van den Berk SA; Vriens MR; Borel Rinkes IH; Valk GD; van Dalen T; de Klerk JM; de Keizer B
    Nucl Med Commun; 2016 Dec; 37(12):1246-1252. PubMed ID: 27612033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.